Publications

Detailed Information

O-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocation

DC Field Value Language
dc.contributor.authorPark, Jungeun-
dc.contributor.authorHan, Dohyun-
dc.contributor.authorKim, Kyunggon-
dc.contributor.authorKang, Yup-
dc.contributor.authorKim, Youngsoo-
dc.date.accessioned2012-07-03T00:58:16Z-
dc.date.available2012-07-03T00:58:16Z-
dc.date.issued2009-02-
dc.identifier.citationBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS; Vol.1794 2; 254-262ko_KR
dc.identifier.issn1570-9639-
dc.identifier.urihttps://hdl.handle.net/10371/78164-
dc.description.abstractGlyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a typical glycolytic enzyme comprised of four identical 37 kDa subunits. In addition to its glycolytic function, GAPDH has a number of biological functions which are related to its subcellular localization. Generally, protein O-linked N-acetylglucosamine modification (O-GlcNAcylation) is considered, among other effects, to mediate the nuclear transportation of cytosolic proteins. To elucidate the effect of O-GlcNAcylation on GAPDH. we determined the location of the O-GlcNAcylation site by tandem mass spectrometry, and subsequently examined the biological significance of this derivatization. The site involved was identified to be Thr227 by beta-elimination and Michael addition. Transient transfection assays demonstrated that the T227A mutation induced the cytoplasmic accumulation of GAPDH, whereas the wild type was present in the cytoplasm and nuclei. Structural modeling, mutagenesis of Thr227 to Lys and Arg, and gel filtration chromatography of mutated and wild type GAPDH, together suggested that O-GlcNAcylation at Thr227 interrupts the hydrophobic interfaces formed between GAPDH monomers in its tetrameric state. The present study identified Thr227 as the major GAPDH O-GlcNAcylation site, which suggests that this modification mediates the nuclear translocation of GAPDH, presumably by disrupting the conformation of tetrameric GAPDH. (C) 2008 Elsevier B.V. All rights reserved.ko_KR
dc.description.sponsorshipThis work was supported by a grant from the Innovative Research
Institute for Cell Therapy, Republic of Korea (#A062260) and by a grant
from the Korean Science and Engineering Foundation (KOSEF) grant
funded by the Korean government (MOST; R01-2006-000-10248-0).
ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectbeta-elimination and Michael additionko_KR
dc.subjectO-GlcNAcylationko_KR
dc.subjectPost-translational modificationko_KR
dc.subjectGAPDHko_KR
dc.subjectStructural biologyko_KR
dc.titleO-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocationko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박정은-
dc.contributor.AlternativeAuthor한도현-
dc.contributor.AlternativeAuthor김경곤-
dc.contributor.AlternativeAuthor강엽-
dc.contributor.AlternativeAuthor김영수-
dc.identifier.doi10.1016/j.bbapap.2008.10.003-
dc.citation.journaltitleBIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS-
dc.description.citedreferenceBarbini L, 2007, MOL CELL BIOCHEM, V300, P19, DOI 10.1007/s11010-006-9341-1-
dc.description.citedreferenceAndrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200-
dc.description.citedreferenceRaman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200-
dc.description.citedreferenceCarujo S, 2006, ONCOGENE, V25, P4033, DOI 10.1038/sj.onc.1209433-
dc.description.citedreferenceKim HS, 2006, FEBS LETT, V580, P2311, DOI 10.1016/j.febslet.2006.03.043-
dc.description.citedreferenceJenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289-
dc.description.citedreferenceMajumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M51123200-
dc.description.citedreferenceBae Byoung-Il, 2006, Proc Natl Acad Sci U S A, V103, P3405, DOI 10.1073/pnas.0511316103-
dc.description.citedreferenceWhelan SA, 2006, METHOD ENZYMOL, V415, P113, DOI 10.1016/S0076-6879(06)15008-9-
dc.description.citedreferencePerani M, 2005, J BIOL CHEM, V280, P42863, DOI 10.1074/jbc.M502963200-
dc.description.citedreferencePark J, 2005, J BIOCHEM MOL BIOL, V38, P725-
dc.description.citedreferenceHara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268-
dc.description.citedreferenceSirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399-
dc.description.citedreferenceMazzola JL, 2005, BBA-GEN SUBJECTS, V1722, P168, DOI 10.1016/j.bbagen.2004.12.010-
dc.description.citedreferenceVosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066-
dc.description.citedreferenceChuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902-
dc.description.citedreferenceLove D. C., 2005, SCI STKE, pre13, DOI DOI 10.1126/STKE.3122005RE13-
dc.description.citedreferenceLiu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101-
dc.description.citedreferenceZachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016-
dc.description.citedreferenceMonsigny M, 2004, BBA-GEN SUBJECTS, V1673, P94, DOI 10.1016/j.bbagen.2004.03.015-
dc.description.citedreferenceGewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200-
dc.description.citedreferenceZheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X-
dc.description.citedreferenceMazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484-
dc.description.citedreferenceWells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200-
dc.description.citedreferenceMazzola JL, 2002, NEUROTOXICOLOGY, V23, P603, DOI 10.1016/S0161-813X(02)00062-1-
dc.description.citedreferenceLiu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820-
dc.description.citedreferenceCarlile GW, 2000, MOL PHARMACOL, V57, P2-
dc.description.citedreferenceSirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3-
dc.description.citedreferenceHanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016-
dc.description.citedreferencePetersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5-
dc.description.citedreferenceSirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO-
dc.description.citedreference2-V-
dc.description.citedreferenceArnold CS, 1996, J BIOL CHEM, V271, P28741-
dc.description.citedreferenceHart GW, 1996, GLYCOBIOLOGY, V6, P711, DOI 10.1093/glycob/6.7.711-
dc.description.citedreferenceDUVERGER E, 1995, J CELL SCI, V108, P1325-
dc.description.citedreferenceMANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993-
dc.description.citedreferenceANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499-
dc.description.citedreferenceTORRES CR, 1984, J BIOL CHEM, V259, P3308-
dc.description.tc6-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share